title: Management of subglottic hemangioma.
abstract: OBJECTIVE
  Subglottic hemangioma is a challenging congenital anomaly involving the larynx in children. Management is not uniform, and no single treatment modality has been accepted as ideal. During the last several years only a few articles have dealt with this topic. The purpose of this review is to examine the published literature and discuss the alternative treatments of SGH. The authors also describe their approach and the use of microdebrider as a new surgical tool.
  
  
  RESULTS
  Observation is an option for the rare case of SGH with minimal airway obstruction. However, most cases will require some additional intervention. Systemic steroids intralesional steroid injection, laser ablation with both the CO2 and KTP lasers, interferon (IFN) and open surgical excision have all been utilized.
  
  
  CONCLUSIONS
  The authors found few technical innovations in this field in the last 5 years. All techniques utilized have some degree of success. However, all approaches have downsides and are associated with complications, some of which can be very serious. Ideally, more structured research comparing techniques would be helpful to best determine operative and postoperative management.
authors.affiliation: Department Pediatric Otolaryngology and Head-Neck Surgery, San Diego Children's Hospital, San Diego, California 92123, USA. spransky@chsd.org
authors.forename: Seth M
authors.initials: SM
authors.lastname: Pransky
authors.forename: Cecilia
authors.initials: C
authors.lastname: Canto
mesh_terms: D000970:Antineoplastic Agents / Q000627:therapeutic use; D006391:Hemangioma / Q000175:diagnosis / Q000628:therapy*; D006801:Humans; D000077190:Interferon alpha-2; D016898:Interferon-alpha / Q000627:therapeutic use; D007822:Laryngeal Neoplasms / Q000175:diagnosis / Q000628:therapy*; D053685:Laser Therapy; D011994:Recombinant Proteins
chemical_list: D000970:Antineoplastic Agents; D000077190:Interferon alpha-2; D016898:Interferon-alpha; D011994:Recombinant Proteins